October 24, 2024
TOPLINE: Disparities in emergency department (ED) mortality and patient outcomes after cardiac arrest in the United States emphasize an urgent need for equitable healthcare resources and […]
October 24, 2024
TOPLINE: In critically ill patients, video laryngoscopy offers superior glottic visualization, reduces the incidence of esophageal intubation, and improves the first-attempt success rate of emergency tracheal […]
October 24, 2024
TOPLINE: Mepivacaine instillation significantly reduced pain during intrauterine device (IUD) placement in nulliparous women. More than 90% of women in the intervention group reported tolerable pain […]
October 23, 2024
TOPLINE: A greater percentage of counties with the highest cancer mortalities had no trials vs counties with the lowest cancer mortalities. No trials occurred in 85% […]
October 23, 2024
TOPLINE: Compared with six cycles, three cycles of chemotherapy for high-risk retinoblastoma showed noninferior 5-year disease-free survival (DFS). The three-cycle regimen also resulted in fewer adverse […]
October 22, 2024
TOPLINE: Patients with early-stage triple-negative breast cancer (TNBC) and high immune infiltration showed improved disease-free survival (DFS) with adjuvant capecitabine. These “immune-hot” patients had a 5-year […]
October 22, 2024
TOPLINE: Patients with dry eye disease are more than three times as likely to have mental health conditions, such as depression and anxiety, as those without […]
October 22, 2024
TOPLINE: Guselkumab administered every 8 weeks (Q8W) leads to durable improvement in disease activity along with improvements in both skin and joint symptoms over 2 years […]
October 22, 2024
TOPLINE: Treatment with ritlecitinib sustained hair regrowth through week 48 in patients with alopecia areata (AA), and up to one third of nonresponders at week 24 […]